Get startedLog in
    Picture of Initiator Pharma A/S logo

    INIT — Initiator Pharma A/S News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Initiator Pharma To Start Phase I Pharmacokinetics Study For New Ip2015 Formulations

    Picture of Initiator Pharma A/S logoInitiator Pharma A/S
    20/12/2022 08:11
    Dec 20 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * INITIATOR PHARMA READY TO START PHASE I PHARMACOKINETICS
STUDY
FOR NEW IP2015 FORMULATIONS
    * STUDY EXPECTED TO START IN BEGINNING OF 2023
    * STUDY TO PROVIDE DRAFT PHAMACOKINETIC DATA IN Q2 2023

Source text for Eikon:  ID:nMFN6HvWQ 
Further company coverage:  INIT.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

    Recent news on Initiator Pharma A/S

    See all news